Boathouse Capital and CMS Mezzanine Invest in BioPharm Communications, LLC
April 18, 2012
Boathouse Capital and CMS Mezzanine are pleased to announce an investment in BioPharm Communications, LLC (“BioPharm”) on March 23, 2012.
Headquartered in New Hope, PA, BioPharm is a leading medical communications and marketing agency that specializes in providing non-personal, peer-to-peer solutions to the pharmaceutical and biotechnology industries. BioPharm develops robust clinical content in collaboration with key opinion leaders and delivers it to healthcare practitioners through the company’s comprehensive suite of proprietary branded programs. BioPharm maximizes on-line and offline clinician engagements via its multi-channel “surround sound” delivery capabilities, including targeted direct mail, e-mail, web hosting, web banners/display advertising, search engine marketing, DVDs, mobile devices, selling kits, e-meetings and teleconferences. BioPharm leverages its experienced account managers, streamlined processes and extensive content development expertise across numerous therapeutic classes to deliver campaigns that generate industry leading engagements and returns on investment.
Boathouse and CMS invested subordinated debt and equity in a Southfield Capital Advisors led recapitalization of BioPharm alongside management. BioPharm’s senior management will continue in their current operating roles and will maintain a minority ownership position in the company.